| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9145531 | Cardiovascular Revascularization Medicine | 2005 | 5 Pages |
Abstract
IRT-γ therapy for diffuse ISR lesions with a 21-Gy dose is clinically safe and feasible with marked reduction in late loss but does not confer additional benefit with regard to repeat revascularization and MACE when compared to a dose of 18 Gy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Pramod Kuchulakanti, Rebecca Torguson, Daniel Canos, Lowell F. Satler, William Suddath, Rossana Chan, Larry R. White, Natalie Gevorkian, Anh Bui, Betty Wang, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman,